The global Hepatitis E diagnostic tests market was valued at USD 53.05 million in 2023 and is projected to grow from USD 54.61 million in 2024 to USD 78.62 million by 2032, registering a CAGR of 4.6% during the forecast period. Hepatitis E, a liver disease caused by the Hepatitis E virus (HEV), is a growing public health concern, particularly in developing...